Malignant Otitis Externa

Otolaryngologic Clinics of North America

Volumn 41, Issue 3, 2008, Pages 537-549

  Carfrae, Matthew J ^a   Kesser, Bradley W ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GALLIUM CITRATE GA 67; ITRACONAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

BONE SCINTISCANNING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; EXTERNAL OTITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROBIOLOGICAL EXAMINATION; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PSEUDOMONAS AERUGINOSA; REVIEW; TEMPORAL BONE;

BACTERIAL INFECTIONS; EAR, EXTERNAL; HUMANS; MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; OTITIS EXTERNA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 43049168563     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2008.01.004     Document Type: Review

References (54)

1. Meltzer P.E., and Kelemen G. Pyocutaneous osteomyelitis of the temporal bone, mandible, and zygoma. Laryngoscope 169 (1959) 1300-1316
2. Chandler J.R. Malignant external otitis. Laryngoscope 78 (1968) 1257-1294
3. Nadol Jr. J.B. Histopathology of pseudomonas osteomyelitis of the temporal bone starting as malignant external otitis. Am J Otolaryngol 1 (1980) 359-371
4. Franco-Vidal V., Blanchet H., Bebear C., et al. Necrotizing external otitis: a report of 46 cases. Otol Neurotol 28 (2007) 771-773
5. Berenholz L., Katzenell U., and Harell M. Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa. Laryngoscope 112 (2002) 1619-1622
6. Levenson M.J., Parisier S.C., Dolitsky J., et al. Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO). Laryngoscope 101 (1991) 821-824
7. Mani N., Sudhoff H., Rajagopal S., et al. Cranial nerve involvement in malignant external otitis: implications for clinical outcome. Laryngoscope 117 (2007) 907-910
8. Djalilian H.R., Shamloo B., Thakkar K.H., et al. Treatment of culture-negative skull base osteomyelitis. [see comment]. Otol Neurotol 27 (2006) 250-255
9. Hern J.D., Almeyda J., Thomas D.M., et al. Malignant otitis externa in HIV and AIDS. J Laryngol Otol 110 (1996) 770-775
10. Ress B.D., Luntz M., Telischi F.F., et al. Necrotizing external otitis in patients with AIDS. Laryngoscope 107 (1997) 456-460
11. Yao M., and Messner A.H. Fungal malignant otitis externa due to Scedosporium apiospermum. Ann Otol Rhinol Laryngol 110 (2001) 377-380
12. Castro R., Robinson N., Klein J., et al. Malignant external otitis and mastoiditis associated with an IgG4 subclass deficiency in a child. Del Med J 62 (1990) 1417-1421
13. Paul A.C., Justus A., Balraj A., et al. Malignant otitis externa in an infant with selective IgA deficiency: a case report. Int J Pediatr Otorhinolaryngol 60 (2001) 141-145
14. Sobie S., Brodsky L., and Stanievich J.F. Necrotizing external otitis in children: report of two cases and review of the literature. Laryngoscope 97 (1987) 598-601
15. Wolff L.J. Necrotizing otitis externa during induction therapy for acute lymphoblastic leukemia. Pediatrics 84 (1989) 882-885
16. Tezcan I., Tuncer A.M., Yenicesu I., et al. Necrotizing otitis externa, otitis media, peripheral facial paralysis, and brain abscess in a thalassemic child after allogeneic BMT. Pediatr Hematol Oncol 15 (1998) 459-462
17. Rubin J., Yu V.L., and Stool S.E. Malignant external otitis in children. J Pediatr 113 (1988) 965-970
18. Sreepada G.S., and Kwartler J.A. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg 11 (2003) 316-323
19. Rubin Grandis J., Branstetter IV B.F., and Yu V.L. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis 4 (2004) 34-39
20. Bernheim J., and Sade J. Histopathology of the soft parts in 50 patients with malignant external otitis. J Laryngol Otol 103 (1989) 366-368
21. Naghibi M., Smith R.P., Baltch A.L., et al. The effect of diabetes mellitus on chemotactic and bactericidal activity of human polymorphonuclear leukocytes. Diabetes Res Clin Pract 4 (1987) 27-35
22. Geerlings S.E., and Hoepelman A.I. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26 (1999) 259-265
23. Driscoll P.V., Ramachandrula A., Drezner D.A., et al. Characteristics of cerumen in diabetic patients: a key to understanding malignant external otitis?. Otolaryngol Head Neck Surg 109 (1993) 676-679
24. Holder C.D., Gurucharri M., Bartels L.J., et al. Malignant external otitis with optic neuritis. Laryngoscope 96 (1986) 1021-1023
25. Slattery W.H., and Brackmann D.E. Skull base osteomyelitis: malignant otitis externa. Otolaryngol Clin North Am 29 (1996) 795-806
26. Singh A., Al Khabori M., and Hyder M.J. Skull base osteomyelitis: diagnostic and therapeutic challenges in atypical presentation. Otolaryngol Head Neck Surg 133 (2005) 121-125
27. Bayardelle P., Jolivet-Granger M., and Larochelle D. Staphylococcal malignant external otitis. Can Med Assoc J 126 (1982) 155-156
28. Barrow H.N., and Levenson M.J. Necrotizing 'malignant' external otitis caused by Staphylococcus epidermidis. Arch Otolaryngol Head Neck Surg 118 (1992) 94-96
29. Coser P.L., Stamm A.E., Lobo R.C., et al. Malignant external otitis in infants. Laryngoscope 90 (1980) 312-316
30. Garcia Rodriguez J.A., Montes Martinez I., Gomez Gonzalez J.L., et al. A case of malignant external otitis involving Klebsiella oxytoca. Eur J Clin Microbiol Infect Dis 11 (1992) 75-77
31. Dettelbach M.A., Hirsch B.E., and Weissman J.L. Pseudomonas cepacia of the temporal bone: malignant external otitis in a patient with cystic fibrosis. Otolaryngol Head Neck Surg 111 (1994) 528-532
32. Cunningham M., Yu V.L., Turner J., et al. Necrotizing otitis externa due to Aspergillus in an immunocompetent patient. Arch Otolaryngol Head Neck Surg 114 (1988) 554-556
33. Menachof M.R., and Jackler R.K. Otogenic skull base osteomyelitis caused by invasive fungal infection. Otolaryngol Head Neck Surg 102 (1990) 285-289
34. Kountakis S.E., Kemper Jr. J.V., Chang C.Y., et al. Osteomyelitis of the base of the skull secondary to Aspergillus. Am J Otolaryngol 18 (1997) 19-22
35. Stodulski D., Kowalska B., and Stankiewicz C. Otogenic skull base osteomyelitis caused by invasive fungal infection: case report and literature review. Eur Arch Otorhinolaryngol 263 (2006) 1070-1076
36. Shelton J.C., Antonelli P.J., and Hackett R. Skull base fungal osteomyelitis in an immunocompetent host. Otolaryngol Head Neck Surg 126 (2002) 76-78
37. Bellini C., Antonini P., Ermanni S., et al. Malignant otitis externa due to Aspergillus niger. Scand J Infect Dis 35 (2003) 284-288
38. Sie K.C., Glenn M.G., Hillel A.H., et al. Osteomyelitis of the skull base, etiology unknown. Otolaryngol Head Neck Surg 104 (1991) 252-256
39. Rubin J., Stoehr G., Yu V.L., et al. Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. Arch Otolaryngol Head Neck Surg 115 (1989) 1063-1069
40. Meyers B.R., Mendelson M.H., Parisier S.C., et al. Malignant external otitis. comparison of monotherapy vs combination therapy. Arch Otolaryngol Head Neck Surg 113 (1987) 974-978
41. Grandis J.R., Curtin H.D., and Yu V.L. Necrotizing (malignant) external otitis: prospective comparison of CT and MR imaging in diagnosis and follow-up. Radiology 196 (1995) 499-504
42. Kwon B.J., Han M.H., Oh S.H., et al. MRI findings and spreading patterns of necrotizing external otitis: is a poor outcome predictable?. Clin Radiol 61 (2006) 495-504
43. Strashun A.M., Nejatheim M., and Goldsmith S.J. Malignant external otitis: early scintigraphic detection. Radiology 150 (1984) 541-545
44. Hardoff R., Gips S., Uri N., et al. Semiquantitative skull planar and SPECT bone scintigraphy in diabetic patients: differentiation of necrotizing (malignant) external otitis from severe external otitis. J Nucl Med 35 (1994) 411-415
45. Stokkel M.P., Boot C.N., and van Eck-Smit B.L. SPECT gallium scintigraphy in malignant external otitis: initial staging and follow-up. Case reports. Laryngoscope 106 (1996) 338-340
46. Parisier S.C., Lucente F.E., Som P.M., et al. Nuclear scanning in necrotizing progressive "malignant" external otitis. Laryngoscope 92 (1982) 1016-1019
47. Kimmelman C.P., and Lucente F.E. Use of ceftazidime for malignant external otitis. Ann Otol Rhinol Laryngol 98 (1989) 721-725
48. Johnson M.P., and Ramphal R. Malignant external otitis: report on therapy with ceftazidime and review of therapy and prognosis. Rev Infect Dis 12 (1990) 173-180
49. Cunha B.A. Pseudomonas aeruginosa: resistance and therapy. Semin Respir Infect 17 (2002) 231-239
50. Kraus D.H., Rehm S.J., and Kinney S.E. The evolving treatment of necrotizing external otitis. Laryngoscope 98 (1988) 934-939
51. Narozny W., Kuczkowski J., Stankiewicz C., et al. Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment. Eur Arch Otorhinolaryngol 263 (2006) 680-684
52. Shupak A., Greenberg E., Hardoff R., et al. Hyperbaric oxygenation for necrotizing (malignant) otitis externa. Arch Otolaryngol Head Neck Surg 115 (1989) 1470-1475
53. Davis J.C., Gates G.A., Lerner C., et al. Adjuvant hyperbaric oxygen in malignant external otitis. Arch Otolaryngol Head Neck Surg 118 (1992) 89-93
54. Phillips J.S., and Jones S.E. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev 2 (2005) CD004617